Literature DB >> 14691011

Inhibition of death-receptor mediated apoptosis in human adipocytes by the insulin-like growth factor I (IGF-I)/IGF-I receptor autocrine circuit.

Pamela Fischer-Posovszky1, Hans Tornqvist, Klaus-Michael Debatin, Martin Wabitsch.   

Abstract

Adipose tissue mass is reflected by the volume and the number of adipocytes and is subject to homeostatic regulation involving cell death mechanisms. In this study we have investigated the mechanisms of apoptosis in human preadipocytes and adipocytes that may play a role in the regulation of adipose tissue mass. We found that death receptors (CD95, TNF-related apoptosis-inducing ligand receptors 1 and 2, and TNF receptor 1) are expressed in human fat cells and that apoptosis can be induced by specific ligands. Sensitivity to apoptosis could be stimulated by an inhibitor of biosynthesis. In addition, inhibition of auto-/paracrine action of IGF-I dramatically sensitizes human adipocytes for death ligand-induced apoptosis. Phosphoinositide 3-kinase and, to a weaker extent, p38 MAPK are involved in IGF-I-mediated survival. IGF-I protects human fat cells from apoptosis by maintaining the expression of antiapoptotic proteins, Bcl-x(L) and Fas-associated death domain-like IL-1-converting enzyme inhibitory protein. In conclusion, we identified mechanisms of apoptosis induction in human fat cells. We furthermore demonstrate that human fat cells protect themselves from apoptosis by IGF-I in an auto-/paracrine manner.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14691011     DOI: 10.1210/en.2003-0985

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  18 in total

1.  The role of AEBP1 in sex-specific diet-induced obesity.

Authors:  Lei Zhang; Shannon P Reidy; Tara E Nicholson; Hyun-Jeong Lee; Amin Majdalawieh; Chris Webber; Bruce R Stewart; Peter Dolphin; Hyo-Sung Ro
Journal:  Mol Med       Date:  2005 Jan-Dec       Impact factor: 6.354

Review 2.  Macrophage-induced adipose tissue dysfunction and the preadipocyte: should I stay (and differentiate) or should I go?

Authors:  Alexander Sorisky; André S D Molgat; AnneMarie Gagnon
Journal:  Adv Nutr       Date:  2013-01-01       Impact factor: 8.701

3.  TNF-related apoptosis-inducing ligand promotes human preadipocyte proliferation via ERK1/2 activation.

Authors:  Jan-Bernd Funcke; Verena Zoller; Muad Abd El Hay; Klaus-Michael Debatin; Martin Wabitsch; Pamela Fischer-Posovszky
Journal:  FASEB J       Date:  2015-04-09       Impact factor: 5.191

4.  Differential roles of CIDEA and CIDEC in insulin-induced anti-apoptosis and lipid droplet formation in human adipocytes.

Authors:  Minoru Ito; Michiaki Nagasawa; Tomoko Hara; Tomohiro Ide; Koji Murakami
Journal:  J Lipid Res       Date:  2010-02-14       Impact factor: 5.922

5.  Genetic variation in APOJ, LPL, and TNFRSF10B affects plasma fatty acid distribution in Alaskan Eskimos.

Authors:  V Saroja Voruganti; Shelley A Cole; Sven O E Ebbesson; Harald H H Göring; Karin Haack; Sandra Laston; Charlotte R Wenger; M Elizabeth Tejero; Richard B Devereux; Richard R Fabsitz; Jean W MacCluer; Jason G Umans; Barbara V Howard; Anthony G Comuzzie
Journal:  Am J Clin Nutr       Date:  2010-04-21       Impact factor: 7.045

6.  Committed subcutaneous preadipocytes are reduced in human obesity.

Authors:  Y Tchoukalova; C Koutsari; M Jensen
Journal:  Diabetologia       Date:  2006-11-10       Impact factor: 10.122

7.  Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab.

Authors:  Josep Tabernero; Sant P Chawla; Hedy Kindler; Karen Reckamp; E Gabriela Chiorean; Nilofer S Azad; A Craig Lockhart; Cheng-Pang Hsu; Nigel F Baker; Francesco Galimi; Pedro Beltran; José Baselga
Journal:  Target Oncol       Date:  2014-05-11       Impact factor: 4.493

8.  Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice.

Authors:  Stephan Wueest; Reto A Rapold; Desiree M Schumann; Julia M Rytka; Anita Schildknecht; Ori Nov; Alexander V Chervonsky; Assaf Rudich; Eugen J Schoenle; Marc Y Donath; Daniel Konrad
Journal:  J Clin Invest       Date:  2009-12-01       Impact factor: 14.808

9.  Lower visceral and subcutaneous but higher intermuscular adipose tissue depots in patients with growth hormone and insulin-like growth factor I excess due to acromegaly.

Authors:  Pamela U Freda; Wei Shen; Steven B Heymsfield; Carlos M Reyes-Vidal; Eliza B Geer; Jeffrey N Bruce; Dympna Gallagher
Journal:  J Clin Endocrinol Metab       Date:  2008-03-18       Impact factor: 5.958

Review 10.  Adipocyte cell death, fatty liver disease and associated metabolic disorders.

Authors:  Akiko Eguchi; Ariel E Feldstein
Journal:  Dig Dis       Date:  2014-07-14       Impact factor: 2.404

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.